Top Stories

Covid variant from South Africa was able to ‘break through’ Pfizer vaccine in Israeli study


An Israeli health worker of the Maccabi Healthcare Services prepares to administer a dose of the Pfizer-BioNtech vaccine on February 24, 2021 in Tel Aviv.

Jack Guez | AFP | Getty Images

The coronavirus variant first discovered in South Africa is able to evade some of the protection of the PfizerBioNTech vaccine, according to a new Israeli study, which has not yet been peer-reviewed.

Researchers at Tel Aviv University and Clalit, the largest health-care organization in Israel, examined nearly 400 people who had tested positive for Covid-19 after receiving at least one dose of the vaccine. They compared them to the same number of people who were infected and unvaccinated.

The researchers…


Earnings should boost hot bank trades: RBC’s Gerard Cassidy

Previous article

Powell says it’s ‘highly unlikely’ the Fed will raise rates this year, despite stronger economy

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories